Zarontin (ethosuximide)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) May 2016 WARNINGS Serious Dermatologic Reactions Serious dermatologic reactions, including Stevens-Johnson syndrome (SJS), have...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts